Carvalho Suzana Gonçalves, Silvestre Amanda Letícia Polli, Martins Dos Santos Aline, Fonseca-Santos Bruno, Rodrigues Winner Duque, Palmira Daflon Gremião Maria, Chorilli Marlus, Villanova Janaína Cecília Oliveira
School of Pharmaceutical Sciences, São Paulo State University, UNESP, Department of Drugs and Medicines, 14800-903 Araraquara, SP, Brazil.
School of Pharmaceutical Sciences, São Paulo State University, UNESP, Department of Drugs and Medicines, 14800-903 Araraquara, SP, Brazil.
Int J Pharm. 2021 Jul 15;604:120756. doi: 10.1016/j.ijpharm.2021.120756. Epub 2021 May 29.
One of the challenges to the success of veterinary pharmacotherapy is the limited number of drugs and dosage forms available exclusively to this market, due to the interspecies variability of animals, such as anatomy, physiology, pharmacokinetics, and pharmacodynamics. For this reason, studies in this area have become a highlight, since they are still scarce in comparison with those on human drug use. To overcome many limitations related to the bioavailability, efficacy, and safety of pharmacotherapy in animals, especially livestock and domestic animals, polymers-based drug delivery systems are promising tools if they guarantee greater selectivity and less toxicity in dosage forms. In addition, these tools may be developed according to the great interspecies variability. To contribute to these discussions, this paper provides an updated review of the major polymer-based drug delivery systems projected for veterinary use. Traditional and innovative drug delivery systems based on polymers are presented, with an emphasis on films, microparticles, micelles, nanogels, nanoparticles, tablets, implants and hydrogel-based drug delivery systems. We discuss important concepts for the veterinarian about the mechanisms of drug release and, for the pharmacist, the advantages in the development of pharmaceutical forms for the animal population. Finally, challenges and opportunities are presented in the field of pharmaceutical dosage forms for veterinary use in response to the interests of the pharmaceutical industry.
兽医药理学疗法取得成功面临的挑战之一是,由于动物之间存在种间差异,如解剖学、生理学、药代动力学和药效学等方面的差异,专门针对该市场的药物和剂型数量有限。因此,该领域的研究成为了一个亮点,因为与人类药物使用的研究相比,这类研究仍然很少。为了克服与动物(尤其是家畜和宠物)药物治疗的生物利用度、疗效和安全性相关的许多限制,如果基于聚合物的药物递送系统能够保证剂型具有更高的选择性和更低的毒性,那么它们将是很有前景的工具。此外,这些工具可以根据巨大的种间差异来开发。为了促进这些讨论,本文对预计用于兽医的主要基于聚合物的药物递送系统进行了最新综述。介绍了基于聚合物的传统和创新药物递送系统,重点介绍了薄膜、微粒、胶束、纳米凝胶、纳米颗粒、片剂、植入物和基于水凝胶的药物递送系统。我们讨论了对兽医来说关于药物释放机制的重要概念,以及对药剂师来说在开发针对动物群体的药物剂型方面的优势。最后,针对制药行业的兴趣,提出了兽用药物剂型领域的挑战和机遇。